Herpes zoster emergence following mRNA COVID-19 vaccine

doi:10.1002/jmv.27036

Case Reports

. 2021 Sep;93(9):5231-5232.

doi: 10.1002/jmv.27036. Epub 2021 May 3.

Herpes zoster emergence following mRNA COVID-19 vaccine

Edward Eid¹, Lina Abdullah¹, Mazen Kurban¹, Ossama Abbas¹

Affiliations

PMID: 33913545
PMCID: PMC8242521
DOI: 10.1002/jmv.27036

Case Reports

Herpes zoster emergence following mRNA COVID-19 vaccine

Edward Eid et al. J Med Virol. 2021 Sep.

. 2021 Sep;93(9):5231-5232.

doi: 10.1002/jmv.27036. Epub 2021 May 3.

Authors

Edward Eid¹, Lina Abdullah¹, Mazen Kurban¹, Ossama Abbas¹

Affiliation

¹ Dermatology Department, American University of Beirut Medical Center, Beirut, Lebanon.

PMID: 33913545
PMCID: PMC8242521
DOI: 10.1002/jmv.27036

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflict of interests.

Figures

**Figure 1**
Confluence of vesicles on an erythematous base on the right thigh in a dermatomal distribution

See this image and copyright information in PMC

Cited by

COVID-19 Vaccine-Associated Ocular Adverse Effects: An Overview.
Ichhpujani P, Parmar UPS, Duggal S, Kumar S. Ichhpujani P, et al. Vaccines (Basel). 2022 Nov 7;10(11):1879. doi: 10.3390/vaccines10111879. Vaccines (Basel). 2022. PMID: 36366386 Free PMC article. Review.
Oral lesions after COVID-19 vaccination: Immune mechanisms and clinical approach.
Khazeei Tabari MA, Najary S, Khadivi G, Yousefi MJ, Samieefar N, Abdollahimajd F. Khazeei Tabari MA, et al. Infect Med (Beijing). 2022 Sep;1(3):171-179. doi: 10.1016/j.imj.2022.06.004. Epub 2022 Jun 19. Infect Med (Beijing). 2022. PMID: 38014364 Free PMC article. Review.
Presumably Corneal Graft Rejection after COVID-19 Vaccination.
Mohammadzadeh M, Hooshmandi S, Jafari M, Hassanpour K. Mohammadzadeh M, et al. Case Rep Ophthalmol. 2022 Jul 15;13(2):562-569. doi: 10.1159/000525631. eCollection 2022 May-Aug. Case Rep Ophthalmol. 2022. PMID: 36160489 Free PMC article.
Insights into the Novel Therapeutics and Vaccines against Herpes Simplex Virus.
Malik S, Sah R, Ahsan O, Muhammad K, Waheed Y. Malik S, et al. Vaccines (Basel). 2023 Jan 31;11(2):325. doi: 10.3390/vaccines11020325. Vaccines (Basel). 2023. PMID: 36851203 Free PMC article. Review.
Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!
Gronbeck C, Grant-Kels JM. Gronbeck C, et al. Clin Dermatol. 2021 Jul-Aug;39(4):674-687. doi: 10.1016/j.clindermatol.2021.05.027. Epub 2021 May 21. Clin Dermatol. 2021. PMID: 34809772 Free PMC article. Review.

See all "Cited by" articles

References

1. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mMRNA COVID‐19 vaccine. N Engl J Med. 2020;383:2603‐2615. - PMC - PubMed
1. Maia CMF, Marques NP, de Lucena EHG, de Rezende LF, Martelli D, Martelli‐Júnior H. Increased number of herpes zoster cases in Brazil related to the COVID‐19 pandemic. Int J Infect Dis. 2021;104:732‐733. - PMC - PubMed
1. Tartari F, Spadotto A, Zengarini C, et al. Herpes zoster in COVID‐19‐positive patients. Int J Dermatol. 2020;59:1028‐1029. - PMC - PubMed
1. Zheng M, Gao Y, Wang G, et al. Functional exhaustion of antiviral lymphocytes in COVID‐19 patients. Cell Mol Immunol. 2020;17:533‐535. - PMC - PubMed
1. Drago F, Ciccarese G, Rebora A, Parodi A. Human herpesvirus‐6, ‐7, and Epstein‐Barr virus reactivation in pityriasis rosea during COVID‐19. J Med Virol. 2021;93(4):1850‐1851. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mMRNA COVID‐19 vaccine. N Engl J Med. 2020;383:2603‐2615. - PMC - PubMed

[2] Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mMRNA COVID‐19 vaccine. N Engl J Med. 2020;383:2603‐2615. - PMC - PubMed

[3] Maia CMF, Marques NP, de Lucena EHG, de Rezende LF, Martelli D, Martelli‐Júnior H. Increased number of herpes zoster cases in Brazil related to the COVID‐19 pandemic. Int J Infect Dis. 2021;104:732‐733. - PMC - PubMed

[4] Maia CMF, Marques NP, de Lucena EHG, de Rezende LF, Martelli D, Martelli‐Júnior H. Increased number of herpes zoster cases in Brazil related to the COVID‐19 pandemic. Int J Infect Dis. 2021;104:732‐733. - PMC - PubMed

[5] Tartari F, Spadotto A, Zengarini C, et al. Herpes zoster in COVID‐19‐positive patients. Int J Dermatol. 2020;59:1028‐1029. - PMC - PubMed

[6] Tartari F, Spadotto A, Zengarini C, et al. Herpes zoster in COVID‐19‐positive patients. Int J Dermatol. 2020;59:1028‐1029. - PMC - PubMed

[7] Zheng M, Gao Y, Wang G, et al. Functional exhaustion of antiviral lymphocytes in COVID‐19 patients. Cell Mol Immunol. 2020;17:533‐535. - PMC - PubMed

[8] Zheng M, Gao Y, Wang G, et al. Functional exhaustion of antiviral lymphocytes in COVID‐19 patients. Cell Mol Immunol. 2020;17:533‐535. - PMC - PubMed

[9] Drago F, Ciccarese G, Rebora A, Parodi A. Human herpesvirus‐6, ‐7, and Epstein‐Barr virus reactivation in pityriasis rosea during COVID‐19. J Med Virol. 2021;93(4):1850‐1851. - PMC - PubMed

[10] Drago F, Ciccarese G, Rebora A, Parodi A. Human herpesvirus‐6, ‐7, and Epstein‐Barr virus reactivation in pityriasis rosea during COVID‐19. J Med Virol. 2021;93(4):1850‐1851. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Herpes zoster emergence following mRNA COVID-19 vaccine

Affiliation

Herpes zoster emergence following mRNA COVID-19 vaccine

Authors

Affiliation

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical